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Abstract The extent to which myosin profiles within aduR fast 
and slow muscles are altered by short-term paralysis remains 
equivocal. We used an array of specific antibodies to identify 
adult and developmental MHC isoforms within EDL and soleus 
muscle fibers, and show a marked multiple expression of MHCs 
with a general shift towards slower and more energy efficient 
MHC profiles after 2 weeks of denervation or TTX nerve 
conduction block. Paralysis also induced marked expression of 
an embryonic MHC within most EDL cell types, and a subtle, 
paralysis-sensitive, expression of ¢x-cardiac MHC within speeific 
EDL and soleus extrafusal fibers. Comparison of treatment 
groups also permitted assessment of the relative influence of 
neural activity versus trophic factors on these isoforms, and 
confirmed activity as a major, but not sole, regulator of MHC 
expression. 
Key words: Myosin; Immunohistochemistry; Activity; 
Trophic mechanism; Embryonic MHC; a-Cardiac MHC 
1. Introduction 
Adult mammalian skeletal muscle fibers differ widely with 
respect to their morphological, biochemical and functional 
characteristics, and are known to display remarkable plasticity 
in response to alterations in neuromuscular usage [1]. A major 
portion of this diversity and capacity to adapt to changing 
functional demands appears to reside in the muscle cell's abil- 
ity to transcribe different isoforms of the myosin heavy chain 
(MHC) component of the myosin molecule. Recent immuno- 
logical techniques have led to the identification of at least four 
major MHC isoforms in adult mammalian skeletal muscle: a 
type I or [3-cardiac MHC and the fast IIa, IIx and l ib MHC 
[2], each encoded by a separate gene from the MHC multigene 
family [3]. The different MHC isoforms, which display distinct 
ATPase activities, appear to relate to the maximal velocity of 
muscle fiber shortening, and the energetic ost of tension de- 
velopment of single muscle fibers [4,5]. 
Previous converging lines of evidence suggest that the rela- 
tionship among MHC composition, ATP hydrolysis and the 
physiological events involved with muscle contraction is un- 
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coupled after complete short-term paralysis. Under such con- 
ditions, skeletal muscles rapidly express muscle regulatory fac- 
tors, as well as metabolic, and other specific myofibrillar pro- 
teins, characteristic of a 'slower' phenotype [6-9], and display 
pronounced contractile slowing [10-13]. Despite these marked 
and rapid transformations, it has generally been assumed that 
the myosin molecule is resistant, or slow to adapt, to complete 
disuse [10,14,15]. Furthermore, of those studies reporting 
changes, the direction of MHC isoform conversions within 
paralyzed fast or slow muscles remains equivocal and appears 
to depend upon the experimental method as well as type and 
developmental stage of the muscle at the onset of disuse [16- 
21]. Similarly, the extent o which the appearance of develop- 
mental configurations of MHC [14-17], or more recently, the 
a-cardiac MHC [22], are involved in extrafusal muscle fiber 
responses to paralysis has yet to be resolved. 
In the present study, we used an array of 12 monoclonal 
antibodies to examine the expression of a, I, IIa, IIx, IIb, 
Emb and developmentally regulated type I MHC isoforms 
in EDL and soleus muscle fibers after a period of short- 
term paralysis induced by denervation or pharmacological 
blockade of sciatic nerve action potentials with tetrodotoxin. 
Comparison of these two models of complete disuse also pro- 
vided insight into the relative contribution of nerve-evoked 
activity and putative chemical factors on the expression of 
these proteins, since during TTX paralysis, axon transport 
and the integrity of synaptic contacts are maintained 
[8,23,24]. Such an assessment appears timely since the extent 
to which trophic mechanisms influence myofibrillar proteins 
remains equivocal [14,25-29]. 
2. Materials and methods 
2.1. Experimental design and methods of paralysis 
Female Sprague-Dawley rats (200-230 g) were assigned to one of 
control (n = 7), denervated (DEN; n = 9) or tetrodotoxin-treated 
(TTX; n = 10) groups. All surgical procedures were performed under 
aseptic onditions on animals anaesthetized with pentobarbital so- 
dium (35 mg/kg i.p.). The musculature in one hindlimb of DEN ani- 
mals was paralyzed by excising a 5 mm segment of the sciatic nerve 
immediately distal to the sciatic notch. In TTX animals, paralysis was 
induced in one hindlimb as described previously [8,24,30]. Briefly, a 
silastic uff was secured around the sciatic nerve distal to the sciatic 
notch and connected via silastic tubing to a mini-osmotic pump (Alza 
Corp., CA) placed subcutaneously on the animals back. This system 
delivered TTX (350 pg/ml) to the nerve over 2 weeks at 0.5 pl/h. The 
efficacy of the nerve conduction block was verified twice daily using 
established ankle reflex criteria [8,24,30], and prior to muscle xcision 
by stimulating the sciatic nerve at supramaximal voltage proximal to 
the cuff. The viability of nerve-muscle contacts was assessed using 
histological nd functional criteria as described previously [8,24,30]. 
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Control animals were implanted with a sham delivery system consist- 
ing of cuff and tubing without osmotic pump. After 2 weeks, EDL 
and soleus muscles were excised, quick frozen in isopentane pre- 
cooled in liquid nitrogen, and stored at -80°C. 
2.2. Immunohistochemistry 
Serial 10 p.m tissue cross-sections were cut from each muscle mid- 
belly and incubated for 1 h at room temperature in a blocking solu- 
tion consisting of 5% goat serum in a carrier solution of 5% BSA in 
PBS. The sections were subsequently incubated at room temperature 
in the appropriate dilution of specific monoclonal antibodies raised 
against ~ (BA-G5), IIa (SC-71), IIb (BF-F3), IIx and IIb (212F), Emb 
(F1.652), Emb, neonatal, IIx and IIb (RT-D9), against all MHC ex- 
cept type IIx (BF-35), and developmentally regulated (A4.840, A4.951 
and N2.261) and adult (BA-D5, BA-F8) epitopes of I MHC [2,31-33]. 
The sections were then rinsed with PBS (3 x 10 min) and incubated for 
2 h at room temperature in peroxidase-labelled goat anti-mouse IgG, 
or IgM in the case of BF-F3 and A4.840 (Sigma, St. Louis, MO). 
After a second PBS rinse, the bound secondary antibodies were vis- 
ualized using DAB (Pierce, Rockford, IL) as a chromogen. For ct 
MHC (BA-G5), procedures were identical except that tissues were 
pre-fixed in 95% methanol (-20°C) and incubated with biotin-conju- 
gated IgG2b (Zymed, San Francisco, CA) as a secondary and in 
A 
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peroxidase-conjugated streptavidin (Vector, Burlingame, CA) prior 
to DAB. 
2.3. Fiber classification based on MHC composition 
Fascicles were randomly selected, each from within six regions of 
the midbelly cross-section. All fibers (> 200/section) within these fas- 
cicles were identified across serial sections using a computer-assisted 
image analysis ystem [24]. Fibers were classified as expressing type I, 
~, IIa, IIx, IIb, or Emb MHC, or as hybrid fibers coexpressing multi- 
ple MHC (Fig. 1). Muscle MHC percent distributions were calculated 
and means compared using an ANOVA. 
3. Results 
3.1. Paralysis-induced expression of  slower adult MHC iso- 
forms 
Both DEN and TTX paralysis induced a general yet distinct 
shift in the expression of adult MHC towards slower isoforms 
within each muscle type. In the paralyzed EDL, the percen- 
tage of fibers expressing l ib  MHC exclusively was ,'~40% 
lower than control (Figs. 2 and 3A), whereas the proport ion 
Fig. 1. Immunohistochemical detection of the various MHC isoforms in denervated EDL muscle fibers. Serial transverse sections were stained 
with monoclonal antibodies against MHC isoforms (A) I, (B) IIa, (C) Emb, (D) Emb, neonatal, IIx, IIb, (E) IIx and IIb, (F) all except IIx, 
(G) lib and (H) or-cardiac. Note that in this figure all antibodies, including BA-G5 for tx MHC, were visualized with indirect immunoperoxi- 
dase staining. Hybrid fibers coexpressing two or more different MHC isoforms are labelled: Emb/IIa (open circles), Emb/IlaJlIx (open trian- 
gles), IIx/IIb (open squares), Emb/I (closed squares), and Emb/IIx (asterisks) MHC are shown. Scale bar = 75 p.m. 
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Fig. 2. Immunohistochemical detection of type IIb MHC in cross-sections of control (A) and denervated (C) EDL muscle fibers and detection 
of type I MHC in sections of control (B) and TTX (D) soleus muscle fibers. Note that fewer EDL fibers stained for lib MHC in C compared 
to A, and that a larger number of soleus fibers stained for I MHC in D than in B. Scale bar = 300 gm for A,C. Scale bar = 200 gm for B,D. 
of fibers expressing IIa MHC either alone or with other iso- 
forms was 30% higher (Table 1, Fig. 3A). Compared to 10% 
in control, 40% of all paralyzed EDL fibers were hybrids co- 
expressing 2-4 different MHC (Figs. 1 and 3A). Although the 
proportion of EDL fibers exclusively expressing type I MHC 
was not different among groups, coexpression of this isoform 
with Emb or other fast MHC was observed after paralysis 
(Fig. 3A). 
In paralyzed soleus muscles, there was an average 25% in- 
crease in the percentage of fibers expressing type I MHC 
(Table 1, Fig. 2), including hybrid fibers coexpressing this 
isoform (Fig. 3B). This appeared to be the result of a shift 
from a fast to slow phenotype within single fibers, since the 
proportion of cells expressing I Ia MHC was 88% lower after 
paralysis (Table 1, Fig. 3B). Despite this trend, approx. 15% 
of paralyzed soleus fibers expressed IIx MHC,  usually in con- 
junction with other isoforms (Fig. 3B). IIx MHC was rare in 
control soleus muscle fibers (1-2/section) and coexpressed 
with IIa. 
Extrafusal fibers expressing type I MHC in control soleus, 
and I or IIb in control EDL, coexpressed faint but detectable 
amounts of et MHC,  an isoform abundant in intrafusal fibers 
within these same muscles (Fig. 4). After short-term paralysis, 
immunolabeling of the ct MHC within EDL fibers expressing 
I or l ib MHC was stronger, whereas in the soleus, expression 
of c~ MHC appeared to be coordinately up-regulated with that 
of I MHC. 
3.2. Expression of developmental MHC isoforms during paraly- 
sis 
Approx. 15% of control soleus fibers, mostly type IIa, ex- 
pressed Emb MHC,  whereas this isoform was absent in con- 
Table 1 
Expression of major MHC types in EDL and soleus muscles 
% fibers expressing MHC 
n I IIa IIx IIb Emb 
Soleus 
CON 7 73.8 (2.4) 29.5 (1.8) - 
TTX 10 94.1 (2.0) ~ 3.9 (1.3) a 12.3 (1.3) a 
DEN 9 90.6 (2.7) a 3.4 (2.8) ~ 17.5 (2.9) ~ 
EDL 
CON 7 3.0 (0.4) 21.5 (3.0) 
TTX 10 5.7 (1.1) 26.0 (2.2) 
DEN 8 4.2 (0.3) 30.2 (2.7) ~ 
14.2 (5.6) 
5.5 (1.3) 
17.5 (2.9) b 
39.8 (1.7) 51.0 (3.2) - 
45.0 (3.6) 40.8 (2.7) a 31.5 (4.0) a 
50.5 (3.7) 32.2 (3.6) a 27.7 (9.6) a 
Values are means (S.E.M.). 
aDenotes a significant difference from control (t7 < 0.05). 
bDenotes a significant difference from TTX group (p < 0.05). 
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Fig. 3. MHC expression within EDL (A) and soleus (B) muscles after control, TTX and DEN conditions. Values are means + S.E.M. MHC 
isoforms are arranged from left to right along the abscissa in the purported transition sequence of adult type MHCs [1,22]. Note that expres- 
sion of the cc MHC is not shown. *Denotes a difference from control (p < 0.05). **Denotes a difference from DEN (p < 0.05). 
trol EDL (Table 1, Fig. 3A). On the other hand, ,,~ 30% of 
paralyzed EDL fibers expressed Emb MHC with I, IIa, or IIx, 
but rarely with IIb MHC (Table 1, Fig. 3A). The proportion 
of soleus fibers expressing Emb MHC after paralysis did not 
differ from control, and was expressed across all cell types. 
Regardless of treatment, EDL and soleus fibers displayed 
adult rather than developmental I MHC staining characteris- 
tics. Specifically, we did not observe any permutation of fibers 
that stained negative with at least one, but not all, of the three 
antibodies recognizing separate pitopes of I MHC sequen- 
tially expressed uring development [31] (data not shown). 
3.3. Nerve-dependent regulation of MHC expression 
The contribution of electrical activity versus trophic factors 
was assessed by comparing MHC isoform distributions after 
denervation and TTX conditions. As with our previous find- 
ings [30], both treatments caused a similar loss in EDL 
(,~40%) and soleus (,~ 50%) muscle mass. Changes in MHC 
distribution profiles between experimental conditions were 
generally comparable (Fig. 3). Nevertheless, ubtle differences 
in MHC expression between treatments were apparent and 
included a significantly lower proportion of fibers expressing 
exclusively IIb MHC in DEN than TTX-treated EDL (Fig. 
3A), and a larger percentage of soleus fibers expressing Emb 
MHC after DEN (17%) compared to TTX (5%) counterparts 
(Table 1). 
4. Discuss ion 
In the present study, we report a rapid shift in the expres- 
sion of prevailing adult MHC isoforms in both fast and slow 
muscles towards those displaying slower and presumably 
more efficient energy utilization characteristics after 2 weeks 
of short-term paralysis. We also show marked multiple ex- 
pression of MHCs, as well as a subtle yet distinct paralysis- 
sensitive incorporation of the c~-cardiac isoform, within spe- 
cific sub-types of EDL and soleus extrafusal fibers. In the 
EDL, complete disuse also induced a rapid and significant 
expression of Emb MHC across most cell types. 
Our results are the first to be consistent with reports of 
rapid, paralysis-induced, contractile slowing, and decreases 
in Ca2+-activated myofibrillar ATPase activities in these mus- 
cle types [7,9-12], suggesting that the relationship among 
MHC isoforms, intrinsic rate of fiber shortening, and myofi- 
brillar energy utilization is maintained uring early post- 
paralysis. Our findings for the EDL, although consistent 
with others [18,20,21], are quite modest compared to the al- 
most complete type I transformation of the rabbit gastrocne- 
mius 2 months subsequent to early (8 days) postnatal dener- 
vation [16], suggesting that the MHC response to this 
condition may be species-, muscle- or developmental stage- 
specific. Similarly complex is the soleus response to paralysis, 
since the overall increase in I MHC was also accompanied by 
I~N. Michel et al.IFEBS Letters 391 (1996) 39-44 43 
C D 
Fig. 4. Labeled avidin-biotin immunohistochemical detection of ~ MHC in the EDL after control (A) and DEN (B) conditions. We observed a 
subtle expression of this isoform in cells also expressing I (straight arrows) or IIb (b) MHC in control EDL, and a stronger labelling of et 
MHC within these cell types after DEN. Immunolabeling of control (C) and DEN (D) soleus indicated that expression of ~ MHC was asso- 
ciated with that of I but not IIa (a) MHC and was upregulated with I MHC during paralysis. Note that only two examples of cells expressing 
I, IIb or IIa MHC are shown in AC. Also note the strong labelling of ct MHC in adult rat intrafusal (curved arrows) and cardiac ventricular 
(E) muscle fibers. Specificity of the BA-G5 antibody for c~ MHC [33] was confirmed in the present study using Western blotting (data not 
shown). Scale bar = 75 gm. 
an induction of the IIx MHC within a subpopulation of fi- 
bers. Indeed, a more substantive paralysis-induced replace- 
ment of slow MHC by fast counterparts may well be a 
long-term (>4 weeks) consequence of this condition 
[18,20,21], or when observed after short-term cordotomy 
[19], reflect the residual muscle activation inherent with this 
model [34]. 
Generally, MHC conversions are proposed to occur to ac- 
commodate cellular ATP requirements a sociated with altered 
contractile demands [1,35]. However, it is now apparent that 
MHC transformations can occur during paralysis, in the ab- 
sence of overt fiber contractile and EMG activity [8] and when 
ATP requirements are very low [7,9]. In light of this and the 
finding that changes in fiber metabolic enzyme profiles appear 
to precede myosin isoform switching [35,36], it is possible that 
changes in enzyme levels influence the expression of specific 
contractile proteins. Indeed, the time course and direction of 
changes in fiber MHC expression appear to coincide with 
rapid decreases in the activities of enzymes of predominant 
metabolic pathways within individual paralyzed cells [8]. For 
instance, fibers which in control display high glycolytic and 
low oxidative profiles (i.e IIb) lose 50% of their glycolytic and 
maintain their oxidative enzyme activities during paralysis, 
thereby presenting metabolic profiles in the range of IIa-IIx 
fibers [8]. From the onset of paralysis, the progressive changes 
in metabolic enzymes may sequentially activate more than one 
MHC gene as specific putative metabolic thresholds are at- 
tained [35]. Such a process could explain the expression of 
multiple MHC in a significant number of paralyzed cells. 
Muscle paralysis has been shown to induce the reexpression 
of developmental isoforms of the MHC [14,17], usually in IIa 
fibers and in amounts uggested to be too small (,~ 1% of 
total MHC) to be functionally relevant [14]. Using a different 
antibody, we report a substantially greater expression of Emb 
MHC in the EDL in response to short-term paralysis, such 
that 30% of fibers expressed this isoform, suggesting that this 
may represent another distinct isoform of Emb MHC (cf. 
[37]). Although these results suggest hat activity is a major 
repressor of Emb MHC in this muscle, it may not be the sole 
modulator since the mRNA for this isoform reappears in 
skeletal muscles after stretch [38], functional overload [39], 
or hypothyroidism [3]. Alternatively, since fibers displaying 
developmental MHC isoforms have lower ATPase activities 
and slower rates of tension development than those with adult 
fast MHC [40], their incorporation may be better suited to the 
changing metabolic profiles of specific cell types, and may be 
of functional relevance, during periods of muscle transforma- 
tion [38]. 
In contrast to the EDL, expression of the Emb MHC in the 
soleus did not appear to be increased as a result of paralysis. 
Indeed, the expression of this protein persists within specific 
control soleus fibers until 16 weeks postnatal [39], suggesting 
that the concurrent activation of a developmental isoform 
replacement program and paralysis response lements may 
have rendered most soleus fibers refractory to its reexpression. 
It is also possible that an early transient elevation in Emb 
MHC went undetected in this muscle. 
The ct-cardiac MHC, a major isoform of rat heart and 
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intrafusal fibers, is known to be present in low amounts in 
specialized skeletal muscles such as the masseter and dia- 
phragm [22]. Until now, evidence for the existence of this 
protein in hindlimb extrafusal fibers has been lacking. Using 
a proven specific antibody for this isoform [33], we were able 
to detect a subtle expression of ~t MHC within control hind- 
limb muscle fibers also expressing I or IIb MHC. We also 
provide evidence of a stronger incorporation of c~ MHC in 
response to paralysis within these cell types in the EDL and a 
coexpression with I MHC in transforming fibers in the paral- 
yzed soleus. Our results coincide with a recent report [22], 
showing that c~ MHC transcripts are expressed at low levels 
in a variety of rabbit hindlimb muscles, particularly in those 
which express ignificant I MHC, and at higher levels in fast 
hindlimb muscles undergoing MHC transformations in re- 
sponse to chronic low frequency electrical stimulation [22]. 
As a result, the et MHC is proposed as an additional element 
in the sequential IIa to I fiber transitions that occur under 
these conditions [22]. Although the correlated appearance of ct 
and I MHC in the short term of paralysis may support this 
contention, it is not clear from our results why the tx MHC 
would be expressed with IIb MHC. Alternatively, the in- 
creased expression of ct MHC during paralysis may occur in 
response to mechanical cues associated with the loss of con- 
tractile activity, as shown in cardiac myocytes [41]. 
Comparison of the expression of MHC after denervation 
and TTX paralysis permitted the assessment of the influence 
of trophic and activity-related mechanisms in the regulation of 
these proteins [14,25]. Consistent with previous studies 
[14,25,30], changes in muscle mass and distribution profiles 
of the various MHC isoforms were generally not different 
between experimental groups. However, we did observe subtle 
differences in MHC expression between treatments, uggesting 
a minor role for nerve-derived chemicals in the regulation of 
this protein. The lack of changes in the order observed in 
studies where the administration of trophic substances attenu- 
ated certain denervation-like changes upon myofibrillar pro- 
teins may be reconciled by the fact that in these reports the 
effect may have been related to the high systemic oncentra- 
tions of these exogenous ubstances [28,29]. 
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